Henry Meds vs Hims for Compounded GLP-1: Provider Comparison

Choosing between Henry Meds and Hims for compounded GLP-1 medications comes down to your priorities: comprehensive care with dedicated physician oversight versus simplified access at a lower price point. Both platforms offer legitimate telehealth services for weight management, but they take distinctly different approaches to patient care and medication delivery.

This comparison examines pricing structures, medication availability, physician quality, patient experience, and clinical oversight to help you determine which platform aligns with your weight loss goals and healthcare preferences. We analyzed current pricing from both providers' websites, reviewed patient testimonials, and evaluated clinical protocols to give you the complete picture.

Quick Verdict: Henry Meds vs Hims

Henry Meds: What You Get

Henry Meds positions itself as a premium telehealth platform specializing in metabolic health and weight management. Founded by physicians who recognized gaps in traditional weight loss care, the platform emphasizes comprehensive medical oversight and personalized treatment protocols.

The consultation process begins with a detailed medical history review and virtual appointment with a board-certified physician, typically an endocrinologist or internal medicine specialist with weight management experience. This initial consultation lasts 30-45 minutes and covers medical history, current medications, weight loss goals, and potential contraindications. Patients receive a personalized treatment plan that may include lifestyle counseling alongside medication therapy.

Pricing structure at Henry Meds:

• Semaglutide (compounded): $297/month for starting doses, up to $397/month for higher maintenance doses
• Tirzepatide (compounded): $397/month for starting doses, up to $497/month for maintenance therapy
• Combination therapies: $447-$597/month depending on medications included
• Initial consultation: $99 (applied toward first month if approved)

Henry Meds sources medications from FDA-registered 503B compounding pharmacies that undergo regular inspections and maintain USP 797 sterile compounding standards. Each prescription includes detailed injection instructions, disposal supplies, and access to a patient portal for tracking progress and communicating with your care team.

The platform provides ongoing medical supervision with monthly check-ins during the first three months, then quarterly appointments for stable patients. Blood work monitoring is recommended every 3-6 months, with Henry Meds coordinating lab orders through Quest Diagnostics or LabCorp.

Pros of Henry Meds:

• Dedicated physician relationship with specialists
• Multiple GLP-1 medication options including tirzepatide
• Comprehensive lab monitoring and follow-up
• Fast shipping with temperature-controlled packaging
• Detailed patient education and support resources

Cons of Henry Meds:

• Higher monthly costs compared to basic telehealth options
• No insurance coverage accepted
• Limited availability in some states
• Requires more time commitment for appointments and monitoring

Hims: What You Get

Hims has expanded its direct-to-consumer healthcare model to include weight management through compounded semaglutide offerings. The platform focuses on accessibility and simplified care delivery, making GLP-1 medications available through a simplified telehealth process.

The Hims consultation process is designed for efficiency. Patients complete an online medical questionnaire that takes 10-15 minutes, covering basic health history, current medications, and weight loss goals. A licensed physician reviews the submission and determines eligibility, typically within 24-48 hours. Approved patients receive their medication without a live video consultation unless specifically requested.

Pricing structure at Hims:

• Semaglutide (compounded): $199/month for starter kit including lower doses
• Semaglutide maintenance: $299/month for standard therapeutic doses
• Semaglutide high-dose: $399/month for maximum strength formulations
• Consultation fee: Included in monthly subscription

Hims partners with licensed compounding pharmacies to provide semaglutide formulations in pre-filled syringes or vials with separate syringes. The medication ships in insulated packaging with ice packs to maintain proper temperature during transit. Patients receive basic injection training materials and access to customer support through chat or email.

The platform's approach to ongoing care is more hands-off compared to specialized weight management clinics. Patients can message their assigned physician through the Hims portal, but routine follow-ups are not automatically scheduled. The platform recommends patients consult with their primary care physician for lab monitoring and comprehensive health assessments.

Hims has built its reputation on treating sensitive health conditions discreetly and affordably. The weight management program follows this model, emphasizing privacy and convenience over intensive medical supervision. Patients appreciate the straightforward ordering process and competitive pricing.

Pros of Hims:

• Lower monthly costs and transparent pricing
• Quick, simplified consultation process
• Established telehealth platform with good customer service
• Discreet packaging and delivery
• Easy medication refills and account management

Cons of Hims:

• Limited medication options (semaglutide only)
• Minimal ongoing physician oversight
• No specialized weight management expertise
• Basic patient education and support materials
• Less comprehensive approach to metabolic health

Price Comparison: Henry Meds vs Hims

The cost difference between these platforms reflects their different approaches to patient care. Hims offers the more budget-friendly option, with compounded semaglutide starting at $199 per month compared to Henry Meds' $297 starting price. However, the pricing gap narrows when you factor in the level of medical oversight and additional services included.

Henry Meds' higher pricing includes dedicated physician time, comprehensive medical review, and ongoing monitoring that would typically cost additional fees elsewhere. The platform's physicians spend significantly more time with each patient, conducting thorough consultations and providing personalized treatment adjustments based on progress and side effects.

For patients requiring higher doses of semaglutide, both platforms reach similar price points. Hims charges $399 monthly for maximum-strength formulations, while Henry Meds charges $397 for comparable doses. The difference becomes more pronounced with tirzepatide, which Henry Meds offers at $397-$497 monthly while Hims doesn't provide this newer, often more effective medication.

Neither platform accepts insurance coverage for compounded GLP-1 medications, as these formulations are not covered by most insurance plans. Both companies do accept HSA and FSA payments, which can provide tax advantages for eligible patients. Some patients find the out-of-pocket costs comparable to insurance copays for brand-name medications like Ozempic or Wegovy, especially when factoring in deductibles.

The total cost of treatment should include potential additional expenses. Henry Meds coordinates lab work but patients pay separately for blood tests through their chosen laboratory. Hims patients may need to arrange their own lab monitoring through their primary care physician or pay out-of-pocket for testing.

Medication Options: Henry Meds vs Hims

Henry Meds provides significantly more medication variety for weight management, offering both semaglutide and tirzepatide formulations along with combination therapies. This broader formulary allows physicians to tailor treatment based on individual patient response and tolerance profiles.

The platform's semaglutide formulations are available in multiple concentrations, allowing for precise dose titration. Patients typically start at 0.25mg weekly and gradually increase to therapeutic doses of 1.0-2.4mg weekly based on tolerance and effectiveness. Henry Meds also offers combination formulations that include additional compounds like B vitamins or amino acids, though clinical evidence for these additions remains limited.

Tirzepatide availability gives Henry Meds a significant advantage for patients who don't respond optimally to semaglutide. Clinical trials show tirzepatide may produce greater weight loss than semaglutide, with patients in the SURMOUNT-1 trial losing an average of 20.9% of body weight on the highest dose compared to 12.4% with maximum-dose semaglutide in STEP trials.

Hims focuses exclusively on compounded semaglutide, offering this medication in three strength tiers. While this simplified approach may seem limiting, semaglutide remains highly effective for most patients and has the most extensive safety data among GLP-1 receptor agonists.

The semaglutide formulations at Hims are sourced from FDA-registered compounding pharmacies and undergo stability testing to ensure potency throughout their shelf life. The platform provides clear dosing instructions and titration schedules that follow established clinical protocols.

Both platforms use compounded versions of these medications rather than brand-name formulations like Ozempic or Wegovy. Compounded medications are legal and regulated but may have slight variations in potency compared to FDA-approved branded versions. The cost savings make treatment accessible to patients who cannot afford brand-name options or lack insurance coverage.

Doctor Quality and Oversight

Henry Meds emphasizes physician specialization and ongoing supervision, with most prescribers holding board certifications in endocrinology, internal medicine, or obesity medicine. The platform recruits physicians with specific experience in metabolic disorders and weight management, ensuring patients receive care from providers who understand the complexities of GLP-1 therapy.

Patients are assigned a dedicated physician who manages their care throughout treatment. This continuity allows for better tracking of progress, side effect management, and dose adjustments based on individual response patterns. The initial consultation includes comprehensive medical screening to identify contraindications and optimize treatment safety.

Henry Meds physicians follow established protocols for GLP-1 therapy monitoring, including regular assessment of gastrointestinal side effects, blood glucose changes in diabetic patients, and potential drug interactions. The platform maintains detailed medical records and coordinates with patients' primary care physicians when requested.

Hims uses a network model with licensed physicians who may not have specialized training in weight management or endocrinology. The platform's physicians are licensed and qualified to prescribe these medications, but the level of specialization varies. Most patient interactions occur through messaging rather than live consultations.

The simplified approach at Hims means less intensive medical oversight, which may be appropriate for healthy patients without complex medical histories. However, patients with diabetes, eating disorders, or multiple medications may benefit from the more comprehensive supervision available through specialized platforms.

Both platforms require physician approval before dispensing medications and maintain medical records according to HIPAA requirements. The key difference lies in the depth of ongoing medical management and the level of physician expertise in metabolic medicine.

Patient Experience and Reviews

Henry Meds patients frequently praise the personalized attention and medical expertise they receive, according to reviews on independent platforms like Trustpilot and Google. Many patients report feeling more confident in their treatment plan due to the comprehensive consultations and regular follow-up appointments.

Common positive feedback includes appreciation for the detailed explanation of medication effects, proactive side effect management, and willingness of physicians to adjust treatment based on individual response. Patients also value the coordination of lab work and the platform's communication with their existing healthcare providers.

Some Henry Meds patients note the higher cost as a concern, but many feel the additional medical oversight justifies the expense. The platform maintains a 4.2-star average rating across review platforms, with most complaints related to pricing rather than quality of care.

Hims patients appreciate the convenience and affordability of the platform, with many reviews highlighting the simple ordering process and quick medication delivery. The simplified approach appeals to patients who prefer minimal healthcare interaction and want straightforward access to treatment.

Positive Hims reviews frequently mention the discreet packaging, responsive customer service, and transparent pricing structure. Patients who have used other Hims services often appreciate the familiar interface and consistent experience across different treatments.

Critical feedback for Hims sometimes centers on the limited physician interaction and basic level of medical guidance provided. Some patients express concern about the minimal follow-up and prefer more comprehensive medical oversight, especially when experiencing side effects or needing dose adjustments.

Both platforms maintain generally positive patient satisfaction ratings, with the choice often coming down to individual preferences for medical oversight versus convenience and cost considerations.

Which Is Right for You?

Choose Henry Meds if you:

• Want specialized physician oversight from endocrinology or obesity medicine experts
• Have complex medical conditions like diabetes that require careful monitoring
• Are interested in trying tirzepatide or combination therapies
• Prefer comprehensive medical management and regular follow-up appointments
• Value detailed patient education and support throughout treatment
• Can afford the higher monthly costs for enhanced medical supervision

Choose Hims if you:

• Want the most affordable access to compounded semaglutide
• Prefer a simplified, low-touch healthcare experience
• Are generally healthy without complex medical conditions
• Value convenience and quick medication delivery
• Have experience managing your own health and medication adjustments
• Want to minimize time spent on medical appointments and follow-ups

For patients seeking a middle ground between comprehensive medical oversight and accessible pricing, FormBlends offers physician-supervised GLP-1 therapy with competitive pricing and personalized treatment protocols. Our clinical team provides specialized weight management expertise while maintaining cost-effective treatment options.

Frequently Asked Questions

Is compounded semaglutide from Henry Meds or Hims as effective as Ozempic?

Compounded semaglutide contains the same active ingredient as brand-name Ozempic and works through the same mechanism of action. While compounded versions may have slight variations in potency compared to FDA-approved formulations, clinical outcomes are generally comparable when sourced from reputable compounding pharmacies that follow USP standards.

Can I switch between Henry Meds and Hims if I'm not satisfied?

Yes, you can discontinue service with either platform and transfer your care elsewhere. Both platforms operate on monthly subscription models without long-term contracts. However, you should consult with a physician before making changes to ensure proper dose transition and avoid treatment gaps that could affect your progress.

Do Henry Meds or Hims require lab work before prescribing GLP-1 medications?

Henry Meds typically requires baseline lab work including comprehensive metabolic panel, HbA1c, and lipid profile before starting treatment, especially for patients with diabetes or metabolic conditions. Hims may recommend lab work but doesn't always require it for healthy patients. Both platforms suggest ongoing monitoring every 3-6 months during treatment.

What happens if I experience side effects with either platform?

Henry Meds provides direct access to your prescribing physician for side effect management and dose adjustments. Hims patients can message their assigned physician through the platform portal, though response times may vary. Both platforms can adjust doses or discontinue treatment if side effects become problematic.

How do shipping and storage work for these medications?

Both platforms ship medications in temperature-controlled packaging with ice packs to maintain proper refrigeration during transit. Henry Meds typically ships within 2-3 business days, while Hims ships within 3-5 business days. Medications must be refrigerated upon arrival and should not be frozen or exposed to high temperatures.

Ready to Start Your Weight Loss Goals?

Choosing the right telehealth platform for GLP-1 therapy depends on your individual needs, medical complexity, and preferences for physician oversight. Both Henry Meds and Hims offer legitimate pathways to accessing these effective weight loss medications, with different approaches to patient care and pricing.

If you're looking for comprehensive medical supervision with competitive pricing, consider exploring FormBlends' physician-supervised weight management program. Our clinical team combines the personalized attention of specialized providers with accessible pricing and evidence-based treatment protocols.

Take our free physician assessment to determine if GLP-1 therapy is appropriate for your weight loss goals and medical history. Our board-certified physicians provide the expertise and ongoing support you need for successful, sustainable weight management.

Sources

• Henry Meds Official Website - Pricing and Services. Accessed March 2026. https://henrymeds.com
• Hims Weight Management Program Details. Accessed March 2026. https://forhims.com
• Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
• Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216.
• FDA Guidance for Industry: Compounding and the FDA. Updated 2023. https://www.fda.gov/drugs/guidance-compliance-regulatory-information/pharmacy-compounding
• United States Pharmacopeia. USP Chapter 797 Pharmaceutical Compounding - Sterile Preparations. 2023.